A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence

Molecular Cell

Volumn 50, Issue 5, 2013, Pages 699-710

  Zheng, Hui ^a   Seit Nebi, Alim ^a,b   Han, Xuemei ^a   Aslanian, Aaron ^a   Tat, John ^a   Liao, Rong ^a   Yates, John R ^a   Sun, Peiqing ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GenWay Biotech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; PRAK PROTEIN; PROTEIN; SYNAPTOPHYSIN; TIP60 PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; ONCOGENE RAS; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SENESCENCE; SIGNAL TRANSDUCTION;

ACETYLATION; CELL AGING; CELL LINE; GENES, RAS; HISTONE ACETYLTRANSFERASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; THREONINE;

EID: 84878860782     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.04.013     Document Type: Article

References (39)

1. Askari N., Diskin R., Avitzour M., Capone R., Livnah O., Engelberg D. Hyperactive variants of p38alpha induce, whereas hyperactive variants of p38gamma suppress, activating protein 1-mediated transcription. J.Biol. Chem. 2007, 282:91-99.
2. Avitzour M., Diskin R., Raboy B., Askari N., Engelberg D., Livnah O. Intrinsically active variants of all human p38 isoforms. FEBS J. 2007, 274:963-975.
3. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
4. Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A., Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B., et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004, 428:431-437.
5. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dörken B., Jenuwein T., Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005, 436:660-665.
6. Charvet C., Wissler M., Brauns-Schubert P., Wang S.J., Tang Y., Sigloch F.C., Mellert H., Brandenburg M., Lindner S.E., Breit B., et al. Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol. Cell 2011, 42:584-596.
7. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005, 436:725-730.
8. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguría A., Zaballos A., Flores J.M., Barbacid M., et al. Tumour biology: senescence in premalignant tumours. Nature 2005, 436:642.
9. Coppé J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 2010, 5:99-118.
10. Courtois-Cox S., Jones S.L., Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene 2008, 27:2801-2809.
11. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garré M., Nuciforo P.G., Bensimon A., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444:638-642.
12. Doyon Y., CÔté J. The highly conserved and multifunctional NuA4 HAT complex. Curr. Opin. Genet. Dev. 2004, 14:147-154.
13. Ferbeyre G., de Stanchina E., Lin A.W., Querido E., McCurrach M.E., Hannon G.J., Lowe S.W. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol. 2002, 22:3497-3508.
14. Fisher J.B., Kim M.S., Blinka S., Ge Z.D., Wan T., Duris C., Christian D., Twaroski K., North P., Auchampach J., Lough J. Stress-induced cell-cycle activation in Tip60 haploinsufficient adult cardiomyocytes. PLoS ONE 2012, 7:e31569. 10.1371/journal.pone.0031569.
15. Gorrini C., Squatrito M., Luise C., Syed N., Perna D., Wark L., Martinato F., Sardella D., Verrecchia A., Bennett S., et al. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature 2007, 448:1063-1067.
16. Haq R., Brenton J.D., Takahashi M., Finan D., Finkielsztein A., Damaraju S., Rottapel R., Zanke B. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 2002, 62:5076-5082.
17. Iwasa H., Han J., Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 2003, 8:131-144.
18. Kwong J., Hong L., Liao R., Deng Q., Han J., Sun P. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. J.Biol. Chem. 2009, 284:11237-11246.
19. Lemercier C., Legube G., Caron C., Louwagie M., Garin J., Trouche D., Khochbin S. Tip60 acetyltransferase activity is controlled by phosphorylation. J.Biol. Chem. 2003, 278:4713-4718.
20. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 1998, 12:3008-3019.
21. Lin S.Y., Li T.Y., Liu Q., Zhang C., Li X., Chen Y., Zhang S.M., Lian G., Liu Q., Ruan K., et al. GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy. Science 2012, 336:477-481.
22. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720-724.
23. Narita M., Lowe S.W. Senescence comes of age. Nat. Med. 2005, 11:920-922.
24. New L., Jiang Y., Zhao M., Liu K., Zhu W., Flood L.J., Kato Y., Parry G.C., Han J. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J. 1998, 17:3372-3384.
25. New L., Jiang Y., Han J. Regulation of PRAK subcellular location by p38 MAP kinases. Mol. Biol. Cell 2003, 14:2603-2616.
26. Nicke B., Bastien J., Khanna S.J., Warne P.H., Cowling V., Cook S.J., Peters G., Delpuech O., Schulze A., Berns K., et al. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol. Cell 2005, 20:673-685.
27. Rokudai S., Laptenko O., Arnal S.M., Taya Y., Kitabayashi I., Prives C. MOZ increases p53 acetylation and premature senescence through its complex formation with PML. Proc. Natl. Acad. Sci. USA 2013, 110:3895-3900.
28. Sapountzi V., Logan I.R., Robson C.N. Cellular functions of TIP60. Int. J. Biochem. Cell Biol. 2006, 38:1496-1509.
29. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
30. Shi Y., Gaestel M. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 2002, 383:1519-1536.
31. Squatrito M., Gorrini C., Amati B. Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol. 2006, 16:433-442.
32. Sun P., Dong P., Dai K., Hannon G.J., Beach D. p53-independent role of MDM2 in TGF-beta1 resistance. Science 1998, 282:2270-2272.
33. Sun Y., Jiang X., Chen S., Fernandes N., Price B.D. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. USA 2005, 102:13182-13187.
34. Sun P., Yoshizuka N., New L., Moser B.A., Li Y., Liao R., Xie C., Chen J., Deng Q., Yamout M., et al. PRAK is essential for ras-induced senescence and tumor suppression. Cell 2007, 128:295-308.
35. Sykes S.M., Mellert H.S., Holbert M.A., Li K., Marmorstein R., Lane W.S., McMahon S.B. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 2006, 24:841-851.
36. Tang Y., Luo J., Zhang W., Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 2006, 24:827-839.
37. Wang W., Chen J.X., Liao R., Deng Q., Zhou J.J., Huang S., Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 2002, 22:3389-3403.
38. Yamagata K., Kitabayashi I. Sirt1 physically interacts with Tip60 and negatively regulates Tip60-mediated acetylation of H2AX. Biochem. Biophys. Res. Commun. 2009, 390:1355-1360.
39. Zhu J., Woods D., McMahon M., Bishop J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 1998, 12:2997-3007.